Concepedia

Xueyan Chen

XC

Statistics

Publications

69

Citations

9K

H-Index

33

Active since

2004

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

Jilin Agricultural University

Second Affiliated Hospital of Zhejiang University

University of British Columbia

Xueyan Chen is an author at Fred Hutch Cancer Center specializing in medicine, cell biology, and pharmacology.

ORCID

Top concepts

Publications per year

2004–2024

69

Publications

69

CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

Cameron J. Turtle, Laïla-Aïcha Hanafi, Carolina Berger et al. · Journal of Clinical Investigation · 2016 · 2.1K citations · Full text

Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy

Kevin A. Hay, Laïla‐Aïcha Hanafi, Daniel Li et al. · Blood · 2017 · 1.1K citations · Full text

Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 <sup>+</sup> and CD4 <sup>+</sup> CD19-specific chimeric antigen receptor–modified T cells

Cameron J. Turtle, Laïla‐Aïcha Hanafi, Carolina Berger et al. · Science Translational Medicine · 2016 · 989 citations

, , +19

Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib

Cameron J. Turtle, Kevin A. Hay, Laïla‐Aïcha Hanafi et al. · Journal of Clinical Oncology · 2017 · 649 citations

Infectious complications of CD19-targeted chimeric antigen receptor–modified T-cell immunotherapy

Joshua A. Hill, Daniel Li, Kevin A. Hay et al. · Blood · 2017 · 541 citations · Full text

1–5 of 69